Login to Your Account

Through the 'Portola': Submarine sandwich grows $150M meatier

By Randy Osborne
Staff Writer

Friday, February 3, 2017

Portola Pharmaceuticals Inc.'s CFO, Mardi Dier, told BioWorld Today the deal with HCRP was "exactly what we planned to do" – add "part two" to the "part one" of nondilutive funding late last year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription